Evidence for medical AI effectiveness is lacking: only 34 of 1,357 FDA-authorized devices registered for prospective studies
A PLOS Digital Health analysis published in August reviewed 1,357 AI/ML devices authorized by the FDA up to 5 December 2025 and found that most had not been clinically tested; only 34 were registered for a prospective study. Nature Medicine argues that trust can be built only through rigorous, real-world prospective clinical studies.
Who is affected and how
- doctor
- Regulatory authorization alone is not evidence of clinical effectiveness, so when choosing a device it is worth asking for prospective data.
- hospital manager
- Procurement should require real-world clinical validation.
- medtech company
- The lack of prospective evidence is a market and credibility risk.
- health policy
- Pressure for regulatory requirements on proof of effectiveness may grow.
Sources
- Prospective evidence for conversational medical AI is hard, but non-negotiable | Nature Medicinenature.com · Sep 14, 2026
- Most FDA-Cleared AI Devices Were Never Clinically Testeduncertaintybydesign.substack.com · Sep 14, 2026
- A.I. and jobs: People keep saying there’s a shortage of nursing jobs. The truth is more subtle and disturbing.slate.com · Sep 14, 2026
- Evidence of medical AI's effectiveness is missing, rollout is slowingaiforradalom.hu · Sep 18, 2026 · magyar
- Medical AI has a proof problem | LavX Newsnews.lavx.hu · Sep 20, 2026 · magyar
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.